ONCOMETHYLOME SCIENCES SA has a total of 32 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SEQUENOM GEMINI LTD, VOGELSTEIN BERT and IHG PHARMACO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 5 | |
#4 | Canada | 4 | |
#5 | Republic of Korea | 2 | |
#6 | China | 1 | |
#7 | Costa Rica | 1 | |
#8 | EAPO (Eurasian Patent Organization) | 1 | |
#9 | Morocco | 1 | |
#10 | Mexico | 1 | |
#11 | New Zealand | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Bierau Katja | 14 |
#2 | Vlassenbroeck Ilse | 11 |
#3 | Esteller Manel | 8 |
#4 | Van Criekinge Wim | 5 |
#5 | Louwagie Joost | 3 |
#6 | Renard Isabelle | 3 |
#7 | Cope Leslie | 2 |
#8 | Van Neste Leander | 2 |
#9 | Baylin Stephen | 2 |
#10 | Herman James | 2 |
Publication | Filing date | Title |
---|---|---|
WO2010102823A1 | Novel markers for bladder cancer detection | |
WO2010020787A1 | Diagnosis and treatment of tumours | |
WO2010004251A1 | Dna methylomes | |
US2009176655A1 | Methylation detection | |
NZ583796A | Improved detection of mage-a expression | |
WO2009036922A2 | Novel markers for bladder cancer detection | |
EP2173897A2 | Improved urine sample collecting and processing | |
US2010285443A1 | Diagnostic Methods for Diseases Caused by a HPV Infection Comprising Determining the Methylation Status of the HPV Genome | |
US2009275632A1 | Methods of diagnosis and treatment | |
EP2010916A2 | Novel tumour suppressor | |
EP1907856A2 | Angiogenesis inhibition based upon icam 1 or junb expression levels |